Tag: biosimilar Trastuzumab
Biocon & Mylan announce positive CHMP opinion for Ogivri, biosimilar Trastuzumab
The endorsement by European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) opens up opportunities towards tapping approximately $1.9 billion market for the product in Europe...………….